Pediatric Neuromyelitis Optica Spectrum Disorder (NMOSD) 1 Year Observational Study

Overview

About this study

The purpose of this study is to collect information on the natural history of neuromyelitis optica spectrum disorder (NMOSD) in pediatric AQP4-IgG seropositive patients in the Mayo Clinic neuromyelitis optica spectrum disorder (NMOSD) Pediatric Repository.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

NMOSD/AQP4-IgG positive at time of enrollment, or historically positive sample tested on a reliable assay [ex. cell based assay (CBA), or fluorescence-activated cell sorting (FACS)].
Diagnosis of NMOSD
Male and female children
Age between 2-17 years at time of enrollment
Ability to give consent/assent (by patient or caregiver) as appropriate per IRB guidelines
Ability and willingness to complete the study

Exclusion Criteria:

Inability to provide informed consent
Inability to complete required forms via phone, mail or email.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status
Rochester, Minn. Mayo Clinic principal investigator Sean Pittock, M.D.	Closed for enrollment

Mayo Clinic Location

Status

Rochester, Minn.

Mayo Clinic principal investigator

Sean Pittock, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Clinical Trials